Lobbying Disclosure Act of 1995 (Section 5) - All Filers Are Required to Complete This Page

9. Check if this filing amends a previously filed version of this report

LOBBYING ACTIVITY. Select as many codes as necessary to reflect the general issue areas in which the registrant engaged in lobbying on behalf of the client during the reporting period. Using a separate page for each code, provide information as requested. Add additional page(s) as needed.

15. General issue area code ANI

16. Specific lobbying issues

No activity

17. House(s) of Congress and Federal agencies Check if None

18. Name of each individual who acted as a lobbyist in this issue area

19. Interest of each foreign entity in the specific issues listed on line 16 above Check if None

​

LOBBYING ACTIVITY. Select as many codes as necessary to reflect the general issue areas in which the registrant engaged in lobbying on behalf of the client during the reporting period. Using a separate page for each code, provide information as requested. Add additional page(s) as needed.

15. General issue area code BUD

16. Specific lobbying issues

Presidents Budget, FY 2019
P.L. 115-141, Consolidated Appropriations Act of 2018, Division H
P.L. 115-123, Bipartisan Budget Act of 2018, Division B
P.L. 115-120, Extension of Continuing Appropriations Act, 2018, Division B
Issues: Support funding for National Institutes of Health (NIH), Agency for Healthcare Research and Quality (AHRQ), Childrens Hospitals Graduate Medical Education (CHGME), Centers for Disease Control and Prevention (CDC), the National Center for Health Statistics (NCHS), the Prevention and Public Health Fund (PPHF), Hospital Preparedness Program, and biodefense and public health preparedness programs. Oppose limitations on facilities and administrative reimbursement. Maintain NIH salary cap at Executive Level II. Oppose reorganization of NIH and AHRQ without stakeholder input and deliberation. Oppose restrictions on fetal tissue and embryonic stem cell research. Support funding for Health Resources and Services Administration (HRSA) and Title VII and Title VIII health professions and nursing education programs. Support funding for CDC Racial and Ethnic Approaches to Community Health program (REACH) and for research on gun violence. Support funding for Department of Education and federal student aid. Support funding to combat opioid epidemic.

P.L. 115-141, Consolidated Appropriations Act, 2018, Division F
P.L. 115-123, Bipartisan Budget Act of 2018, Division B
P.L. 115-120, Extension of Continuing Appropriations Act, 2018, Division B
Issue: Support funding for Veterans Affairs medical research, research infrastructure, and community care. Oppose restrictions on use of canines in VA medical research. Support funding for DOD Congressionally Directed Medical Research Programs (CDMRP)

P.L. 115-141, Consolidated Appropriations Act, 2018, Division B
P.L. 115-123, Bipartisan Budget Act of 2018, Division B
P.L. 115-120, Extension of Continuing Appropriations Act, 2018, Division B
Issue: Support funding for the National Science Foundation (NSF); support repeal of the Tiahrt amendment to allow Bureau of Alcohol, Tobacco, Firearms, and Explosives to release info about firearms database to CDC and NSF.

P.L. 115-123, Bipartisan Budget Act of 2018, Division C and E
Issue: Support budget agreement that raises defense and non-defense spending caps and overrides sequestration. Support funding for the National Health Service Corps (NHSC) and Teaching Health Center Graduate Medical Education (THCGME). Support delay of Medicaid Disproportionate Share Hospital (DSH) cuts, repeal of the Medicare Independent Payment Advisory Board, and passage of S. 870, the Creating High-Quality Results and Outcomes Necessary to Improve Chronic (CHRONIC) Care Act of 2017. Oppose inclusion of report language undermining the transition to a unified graduate medical education accreditation.
Issue: Support the reauthorization of and extension of funding for the Childrens Health Insurance Program (CHIP).

Issue: Oppose Medicare payment reductions as offsets for non-Medicare spending.

Issue: Support emergency supplemental funding for the CDC Public Health Emergency Preparedness Program and the Assistant Secretary for Preparedness and Responses Hospital Preparedness Program.

17. House(s) of Congress and Federal agencies Check if None

U.S. SENATE, U.S. HOUSE OF REPRESENTATIVES, White House Office, Office of Management & Budget (OMB), Health & Human Services - Dept of (HHS), Natl Institutes of Health (NIH), Health Resources & Services Administration (HRSA), Agency for Healthcare Research & Quality (AHRQ), Centers For Disease Control & Prevention (CDC), Centers For Medicare and Medicaid Services (CMS), Veterans Affairs - Dept of (VA)

18. Name of each individual who acted as a lobbyist in this issue area

19. Interest of each foreign entity in the specific issues listed on line 16 above Check if None

​

LOBBYING ACTIVITY. Select as many codes as necessary to reflect the general issue areas in which the registrant engaged in lobbying on behalf of the client during the reporting period. Using a separate page for each code, provide information as requested. Add additional page(s) as needed.

15. General issue area code CPT

16. Specific lobbying issues

Issue: Educate Congress on perspectives from the higher education community regarding technology transfer, the importance of the Bayh-Dole Act to the US patent system, and the impact of sovereign immunity claims on challenges to patents.

H.R.5340, STRONGER Patents Act
Issue: Support efforts to improve and prevent abuse of the U.S. patent system

17. House(s) of Congress and Federal agencies Check if None

U.S. HOUSE OF REPRESENTATIVES, Office of Management & Budget (OMB)

18. Name of each individual who acted as a lobbyist in this issue area

19. Interest of each foreign entity in the specific issues listed on line 16 above Check if None

​

LOBBYING ACTIVITY. Select as many codes as necessary to reflect the general issue areas in which the registrant engaged in lobbying on behalf of the client during the reporting period. Using a separate page for each code, provide information as requested. Add additional page(s) as needed.

15. General issue area code EDU

16. Specific lobbying issues

Issues: Oppose cuts to graduate/professional student loan benefits, including Public Service Loan Forgiveness (PSLF).

H.R. 4223, Protecting Our Students by Terminating Graduate Rates that Add to Debt (POST GRAD) Act
Issue: Support restoring graduate/professional subsidized student loans

S. 850 / H.R.1922, Foreign Medical School Accountability Fairness Act of 2017
Issue: Support transparency for all international medical schools.

H.R. 2373, To amend title XVIII of the Social Security Act
Issue: Support single accreditation system for graduate medical education

H.R. 4508, the Promoting Real Opportunity, Success, and Prosperity through Education Reform (PROSPER) Act
Issue: support graduate/professional student loan benefits, including PSLF. Oppose elimination of GradPLUS. Oppose requirement to separately incorporate specialized accrediting agencies.

17. House(s) of Congress and Federal agencies Check if None

U.S. HOUSE OF REPRESENTATIVES, U.S. SENATE

18. Name of each individual who acted as a lobbyist in this issue area

19. Interest of each foreign entity in the specific issues listed on line 16 above Check if None

​

LOBBYING ACTIVITY. Select as many codes as necessary to reflect the general issue areas in which the registrant engaged in lobbying on behalf of the client during the reporting period. Using a separate page for each code, provide information as requested. Add additional page(s) as needed.

15. General issue area code HCR

16. Specific lobbying issues

S. 455, Restoring Rural Residencies Act of 2017
Issue: Support technical correction to increase access to physician services in rural communities by allowing teaching hospitals to count resident time spent in critical access hospitals for purposes of Medicare GME payments.

Issue: Educate congressional staff on academic medicines missions, including education, research, patient care, GME, workforce, and physician shortages in rural and urban communities.

Issue: Repeal and replace of Affordable Care Act. Support continuation high-quality affordable health insurance through preservation of current levels of health care coverage. Support programs and funds for safety-net providers.

H.R. 3728, Educating Medical Professionals and Optimizing Workforce Efficiency and Readiness (EMPOWER) Act of 2017
Issue: Support reauthorization of Title VII health professions programs

H.R. 959/S. 1109 Title VIII Nursing Workforce Reauthorization Act of 2017
Issue: Support reauthorization of Title VIII nursing workforce development programs

Issue: Educate Congress and support training on substance abuse, pain management, and safe prescribing practices. Strategies to prevent, identify, and treat opioid dependence

Issue: Affirm the safety of vaccines

Issue: Support the Patient Centered Outcomes Research Institute (PCORI)

P.L. 114-255, 21st Century Cures Act
Issue: Support Implementation of 21st Century Cures Act
Issue: Promote resilience of health professionals
Issue: Potential nominations for presidential appointments

Issue: Support policies to address IV fluid shortages exacerbated by hurricanes, and educate Congress on the shortage of IV saline fluid and injectable drug shortage.

H.R. 5247, Trickett Wendler, Frank Mongiello, Jordan McLinn, and Matthew Bellina Right to Try Act.
Issue: Oppose Right to Try legislation that removes safety measures under FDAs current expanded access program.

Issue: Support policies to address the opioid epidemic including improving coverage and payment for non-opioid therapies, enhancing usability of PDMPs, addressing physician shortages, promoting medication assisted treatment, eliminating Medicare limits on in-patient psychiatric hospital treatment, eliminating Medicaid IMD exclusion, aligning privacy regulations and investing in research and education, and reauthorizing the Patient Centered Outcomes Research Institute.

Issue: Support the Hospitals Preparedness Program and the reauthorization of the Pandemic and All Hazards Preparedness Act.

H.R.4776 Hospital Preparedness Reauthorization Act of 2018.
Issue: Support reauthorization of the Hospital Preparedness Program

Issue: Oppose restrictions on fetal tissue and embryonic stem cell research.

Issue: Amend Controlled Substances Act to improve MAT waiver process for qualified health professionals.

H.R. 5261, Treatment, Education, and Community Help to Combat Addiction Act of 2018
Issue: Provide grants to regional Centers of Excellence in substance use disorder education.

Issue: Support legislative solutions to fire arm related injuries and fatalities including research, public health surveillance, and firearm background checks.

17. House(s) of Congress and Federal agencies Check if None

U.S. HOUSE OF REPRESENTATIVES, U.S. SENATE, Health & Human Services - Dept of (HHS), Office of Management & Budget (OMB), White House Office, Health Resources & Services Administration (HRSA), Centers For Medicare and Medicaid Services (CMS), Natl Institutes of Health (NIH), Substance Abuse & Mental Health Services Administration (SAMHSA), Centers For Disease Control & Prevention (CDC), Food & Drug Administration (FDA), Executive Office of the President (EOP), Drug Enforcement Administration (DEA), Vice President of the U.S.

18. Name of each individual who acted as a lobbyist in this issue area

19. Interest of each foreign entity in the specific issues listed on line 16 above Check if None

​

LOBBYING ACTIVITY. Select as many codes as necessary to reflect the general issue areas in which the registrant engaged in lobbying on behalf of the client during the reporting period. Using a separate page for each code, provide information as requested. Add additional page(s) as needed.

15. General issue area code IMM

16. Specific lobbying issues

Executive Orders 13769 and 13780
Issue: Oppose travel suspension from affected countries and suspension of visa interview waiver program. Support policies to ensure timely and predictable processing for immigration of academic medicine community. Filed Amicus Brief with the United States Supreme Court.

S. 1615 / H.R. 3440, Dream Act of 2017
Issue: Support policies allowing undocumented students to attend U.S. medical schools and residency training. Oppose rescission of Deferred Action for Childhood Arrivals (DACA) executive action without permanent replacement. Support Dreamer eligibility for federal student loans.

P.L. 115-141, Consolidated Appropriations Act, 2018, Division M
S. 898, Conrad State 30 and Physician Access Act
Issue: Support reauthorization and expansion of the Conrad 30 J-1 visa waiver program for physicians.

17. House(s) of Congress and Federal agencies Check if None

U.S. HOUSE OF REPRESENTATIVES, U.S. SENATE, Homeland Security - Dept of (DHS), State - Dept of (DOS), Health & Human Services - Dept of (HHS), U.S. Citizenship & Immigration Services (USCIS)

18. Name of each individual who acted as a lobbyist in this issue area

19. Interest of each foreign entity in the specific issues listed on line 16 above Check if None

​

LOBBYING ACTIVITY. Select as many codes as necessary to reflect the general issue areas in which the registrant engaged in lobbying on behalf of the client during the reporting period. Using a separate page for each code, provide information as requested. Add additional page(s) as needed.

15. General issue area code MED

16. Specific lobbying issues

P.L. 114-255, 21st Century Cures Act, Division A
Issue: Support implementation of 21st Century Cures Act, including the Innovation Fund, increased funding for medical research, reducing administrative and regulatory burden on scientists and research institutions, and supporting young investigators.

Issue: Regulation of Laboratory Developed Tests

Issue: Provide comments on revision to the Common Rule

17. House(s) of Congress and Federal agencies Check if None

Office of Management & Budget (OMB), U.S. SENATE, U.S. HOUSE OF REPRESENTATIVES, White House Office, Health & Human Services - Dept of (HHS), Natl Institutes of Health (NIH), Agency for Healthcare Research & Quality (AHRQ), Food & Drug Administration (FDA)

18. Name of each individual who acted as a lobbyist in this issue area

19. Interest of each foreign entity in the specific issues listed on line 16 above Check if None

​

LOBBYING ACTIVITY. Select as many codes as necessary to reflect the general issue areas in which the registrant engaged in lobbying on behalf of the client during the reporting period. Using a separate page for each code, provide information as requested. Add additional page(s) as needed.

15. General issue area code MMM

16. Specific lobbying issues

H.R. 2267/ S. 1301, Resident Shortage Physician Reduction Act of 2017
Issue: Support additional funding of graduate medical education

Issues: Support lifting cap on number of residents Medicare will count when determining teaching hospitals' Medicare Direct Graduate Medical Education (DGME) and Indirect Medical Education (IME) payments

Issue: Oppose reduction of Medicare GME/IME payments

Issue: Oppose reduction in Medicare hospital outpatient department reimbursement.

Issue: Oppose Medicare hospital cuts

Issue: Support Medicare Graduate Medical Education (GME) per resident amount technical corrections and administrative relief.

Issue: Oppose redesign of Medicare Indirect Medical Education financing and redistribution.

P.L. 115-123, Bipartisan Budget Act of 2018, Division E
P.L. 115-120, Extension of Continuing Appropriations Act, 2018, Division C
H.R. 3921, Helping Ensure Access for Little Ones, Toddlers, and Hopeful Youth by Keeping Insurance Delivery Stable (HEALTHY KIDS) Act of 2017
Issue: Support the reauthorization of and extension of funding for the Childrens Health Insurance Program (CHIP).

Issue: Support delay in Medicaid Disproportionate Share Hospital (DSH) cuts

Issue: Development and implementation of new Medicare Disproportionate Share Hospital (DSH) formula required under the ACA.

Issue: Support allowing providers in new delivery models (e.g., ACOs, bundled payments, etc.) to access medical records with information on substance use disorders

Issue: Modify CMS Hospital Compare Star Ratings to allow stakeholders time to work together to address concerns with methodology. Support inclusion of sociodemographic status as part of quality programs

Issue: ACA Section 1115 and 1332 Medicaid Waivers

Issue: ACA Medicaid expansion. Maintain commitment to match State spending on medical care for Medicaid beneficiaries without limits, caps, or block grants. Maintain and enforce network adequacy requirements and mandate sufficient payments to providers.

H.R. 4392, To provide that the provision of the Medicare Program: Hospital Outpatient Prospective Payment and Ambulatory Surgical Center Payment Systems and Quality Reporting Programs final regulation relating to changes in the payment amount for certain drugs and biologicals purchased under the 340B drug discount program shall have no force or effect, and for other purposes.
Issue: Support rescission of Medicare cuts to hospitals that participate in 340B Drug Pricing Program

H.R. 4710, 340B PAUSE Act
Issue: Oppose bill that would impose a moratorium on 340B hospitals and other issues

S. 2312, 340B HELP Act
Issue: Oppose bill that would impose a moratorium and add additional reporting requirements for 340B hospitals

S.2453, Ensuring the Value of the 340B Program Act of 2018
Issue: Oppose bill that would require hospitals to report total 340B acquisition costs

Issue: Support policies to address the opioid epidemic including improving coverage and payment for non-opioid therapies, enhancing usability of PDMPs, addressing physician shortages, promoting medication assisted treatment, eliminating Medicare limits on in-patient psychiatric hospital treatment, eliminating Medicaid IMD exclusion, aligning privacy regulations and investing in research and education, and reauthorizing the Patient Centered Outcomes Research Institute.

Issue: Support a third agreement period for certain Accountable Care Organizations in Medicare Shared Savings Program

Issue: Support a delay in CMS issuing a final national coverage decision until the agency has an opportunity to receive and consider alternatives to limiting coverage to FDA-approved diagnostic tests developed using Next Generation Sequencing technology.

Issue: Support nominees for the Medicare Payment Advisory Committee (MedPAC) and the Medicaid and CHIP Payment and Access Commission (MACPAC)

17. House(s) of Congress and Federal agencies Check if None

U.S. HOUSE OF REPRESENTATIVES, U.S. SENATE, White House Office, Centers For Medicare and Medicaid Services (CMS)

18. Name of each individual who acted as a lobbyist in this issue area

19. Interest of each foreign entity in the specific issues listed on line 16 above Check if None

​

LOBBYING ACTIVITY. Select as many codes as necessary to reflect the general issue areas in which the registrant engaged in lobbying on behalf of the client during the reporting period. Using a separate page for each code, provide information as requested. Add additional page(s) as needed.

15. General issue area code SCI

16. Specific lobbying issues

S. 1519 / H.R. 2810, the National Defense Authorization Act for FY 2018
Issue: Oppose restrictions to Department of Defense medical research

Issue: Support reducing administrative and regulatory burden on scientists and research institutions.

Issue: Support the use of a competitive peer review process for federal research grants and programs

P.L. 114-329, American Innovation and Competitiveness Act
Issue: Support reauthorization of NSF, including NSFs merit-bases peer review process and reducing regulatory burden on scientists

Issue: Support nomination of highly qualified individuals to serve as Director and in other key roles in the Office of Science and Technology Policy (OSTP)

Issue: Oppose Environmental Protection Agency (EPA) directive barring scientists who receive EPA grants from serving in advisory roles

17. House(s) of Congress and Federal agencies Check if None

U.S. HOUSE OF REPRESENTATIVES, U.S. SENATE, White House Office, Environmental Protection Agency (EPA)

18. Name of each individual who acted as a lobbyist in this issue area

19. Interest of each foreign entity in the specific issues listed on line 16 above Check if None

​

LOBBYING ACTIVITY. Select as many codes as necessary to reflect the general issue areas in which the registrant engaged in lobbying on behalf of the client during the reporting period. Using a separate page for each code, provide information as requested. Add additional page(s) as needed.

15. General issue area code VET

16. Specific lobbying issues

S. 2193, Caring for Our Veterans Act of 2017
H.R. 4242, VA Care in the Community Act
S.2184, Veterans Community Care and Access Act of 2017
Draft, VA Coordinated Access Rewarding Experiences (CARE) plan
Issue: Preserve direct sole-source contracting with academic affiliates to improve Veterans access to specialty care at academic medical centers. Support VA physician recruitment through scholarship, loan repayment, and immigration programs.

Issue: Support authority for VA joint ventures with academic affiliates

Issue: Support increased VA GME funding and Medicare GME funding for VA affiliates

Issue: Educate Congress on the importance of the VAs academic affiliates to improve veteran care through clinical, research, tech transfer, and education partnerships. Oppose eliminating authority for academic affiliates to administer NIH grants in support of VA investigators.

Issue: Support continuation of local flexibility and consideration of VAs statutory education and research missions in VA medical center referral determinations and procedures

17. House(s) of Congress and Federal agencies Check if None

Veterans Affairs - Dept of (VA), U.S. HOUSE OF REPRESENTATIVES, U.S. SENATE

18. Name of each individual who acted as a lobbyist in this issue area

19. Interest of each foreign entity in the specific issues listed on line 16 above Check if None

​

LOBBYING ACTIVITY. Select as many codes as necessary to reflect the general issue areas in which the registrant engaged in lobbying on behalf of the client during the reporting period. Using a separate page for each code, provide information as requested. Add additional page(s) as needed.

15. General issue area code LBR

16. Specific lobbying issues

No activity

17. House(s) of Congress and Federal agencies Check if None

18. Name of each individual who acted as a lobbyist in this issue area

19. Interest of each foreign entity in the specific issues listed on line 16 above Check if None

​

LOBBYING ACTIVITY. Select as many codes as necessary to reflect the general issue areas in which the registrant engaged in lobbying on behalf of the client during the reporting period. Using a separate page for each code, provide information as requested. Add additional page(s) as needed.

15. General issue area code TAX

16. Specific lobbying issues

P.L. 115-97, Tax Cuts and Jobs Creation Act
Issue: Track IRS implementation of the excise tax based on investment income of private colleges and universities, the excise tax on compensation for certain employees at tax-exempt organizations, and the provision that would include name and logo royalties under unrelated business income tax.

17. House(s) of Congress and Federal agencies Check if None

U.S. HOUSE OF REPRESENTATIVES, U.S. SENATE

18. Name of each individual who acted as a lobbyist in this issue area

19. Interest of each foreign entity in the specific issues listed on line 16 above Check if None

​

Information Update Page - Complete ONLY where registration information has changed.

20. Client new address

21. Client new principal place of business (if different than line 20)

22. New General description of client’s business or activities

LOBBYIST UPDATE

23. Name of each previously reported individual who is no longer expected to act as a lobbyist for the client

ISSUE UPDATE

24. General lobbying issue that no longer pertains

AFFILIATED ORGANIZATIONS

25. Add the following affiliated organization(s)

Internet Address:

26. Name of each previously reported organization that is no longer affiliated with the registrant or client

FOREIGN ENTITIES

27. Add the following foreign entities:

28. Name of each previously reported foreign entity that no longer owns, or controls, or is affiliated with the registrant, client or affiliated organization